Literature DB >> 3027313

Alpha adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17 beta-estradiol.

V Gisclard, N A Flavahan, P M Vanhoutte.   

Abstract

Experiments were designed to determine the effect of estrogen pretreatment on alpha adrenergic responsiveness of blood vessels of the rabbit. Rabbits were ovariectomized and, after 8 days of recovery, treated with 17 beta-estradiol (100 micrograms i.m.; estrogen group) or solvent (control group) for 4 days. Rings of saphenous vein and femoral artery (both without endothelium) were mounted for isometric tension recording in organ chambers filled with modified Krebs-Ringer bicarbonate solution (37 degrees C), gassed with 95% O2-5% CO2. All experiments were performed in the presence of inhibitors of neuronal uptake, extraneuronal uptake and beta adrenoceptors. In the saphenous vein, the estrogen treatment did not significantly affect the concentration-effect curves evoked by norepinephrine (either under control conditions or after alpha-1 or alpha-2 adrenergic blockade), phenylephrine (an alpha-1 adrenergic agonist) or UK 14,304 (an alpha-2 adrenergic agonist). In the femoral artery, estrogen treatment depressed the contractile responses evoked by norepinephrine (under control conditions) but not those produced by phenylephrine; UK 14,304 did not evoke a contractile response. The depressant effect of estrogen treatment on the concentration-effect curve to norepinephrine in the femoral artery was prevented by the alpha-2 adrenergic antagonist, rauwolscine. The results in the femoral artery but not in the saphenous vein suggest that estrogens depress alpha-2 but not alpha-1 adrenergic responsiveness. In the femoral artery, alpha-2 adrenoceptor stimulation does not cause contraction per se but apparently can facilitate alpha-1 adrenergic responses. This probably results from a reduced density of alpha-2 adrenoceptors in this blood vessel.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027313

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Alpha-adrenergic control of blood flow during exercise: effect of sex and menstrual phase.

Authors:  Jacqueline K Limberg; Marlowe W Eldridge; Lester T Proctor; Joshua J Sebranek; William G Schrage
Journal:  J Appl Physiol (1985)       Date:  2010-08-19

2.  Pharmacological analysis of postjunctional alpha-adrenoceptors mediating contractions to (-)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of alpha 1- and alpha 2-adrenoceptors.

Authors:  C J Daly; J C McGrath; V G Wilson
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

3.  Regional differences in sexually dimorphic protein expression in the spontaneously hypertensive rat (SHR).

Authors:  Douglas S Martin; Olga Klinkova; Kathleen M Eyster
Journal:  Mol Cell Biochem       Date:  2011-10-26       Impact factor: 3.396

4.  Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists.

Authors:  Virginia M Miller; Jay R Kaplan; Nicholas J Schork; Pamela Ouyang; Sarah L Berga; Nanette K Wenger; Leslee J Shaw; R Clinton Webb; Monica Mallampalli; Meir Steiner; Doris A Taylor; C Noel Bairey Merz; Jane F Reckelhoff
Journal:  Biol Sex Differ       Date:  2011-12-12       Impact factor: 5.027

Review 5.  miRNA as a New Regulatory Mechanism of Estrogen Vascular Action.

Authors:  Daniel Pérez-Cremades; Ana Mompeón; Xavier Vidal-Gómez; Carlos Hermenegildo; Susana Novella
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.